St. Jude currently controls nearly a quarter of the CRM, or cardiac rhythm management, market and its new device will only solidify that dominant position. St. Jude is also working on treatments for hypertension, particularly for patients who don't respond to other treatments.
With such revolutionary devices coming to market, Cramer asked Starks about some of his biggest hurdles. Starks noted that our country's current excise tax is a major stumbling block because St. Jude is a huge exporter of devices to patients around the globe.
Cramer said that St. Jude clearly has game-changing technology.
Executive Decision: Stephen Holmes
In his second "Executive Decision" segment, Cramer sat down with Stephen Holmes, chairman and CEO of Wyndham Worldwide (WYN - Get Report), a stock that was down 2.8% Friday on in-line earnings but is up an astounding 1,170%, including reinvested dividends, over the past five years.
Holmes said Wyndham had a great quarter, even better than expected. That hasn't translated to the stock price, however, which is up one day and down the next, he continued.
When asked about using declines to buy back stock, Holmes said Wyndham is always looking for weakness in the shares to buy back as many shares as it can.
Turning to the economy, Holmes said Wyndham is not seeing a slowdown in hotel construction. He said Obamacare is on the minds of many hotel operators, but hasn't caused any properties not to be developed. Instead, operators are simply staffing with fewer employees.
Finally, when asked about rival HomeAway (AWAY), Holmes said the two companies have different models, with Wyndham helping homeowners rent their properties as opposed to HomeAway's listing model.
Cramer reminded viewers that when stocks go down, sometimes it's a buying opportunity -- as it is in the case of Wyndham.